- Open
- 10.25
- High
- 10.06
- Low
- 9.50
- Close
- 10.06
- Change
- -0.75 (-7.32%)
- Volume
- 405,981
| 27 Jul 2026 | 07:00:09 | Holding(s) in Company |
| 21 Jul 2026 | 07:00:03 | Holding(s) in Company |
| 29 Jun 2026 | 07:00:13 | IMC Presentation Statement |
| 25 Jun 2026 | 12:00:00 | Directorate change |
| 23 Jun 2026 | 12:03:41 | Notice of Investor Presentation |
| 16 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 17 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 12 Dec 2023 | Annual Report and Accounts (to 2023-06-30) |
Skinbiotherapeutics PLC is a biotechnology company focused on developing products that enhance skin health. The company utilizes its SkinBiotix® technology, which is based on research by Professor Catherine O'Neill and Professor Andrew McBain. Skinbiotherapeutics operates through multiple subsidiaries, including AxisBiotix Limited, Dermatonics Ltd, and Bio-Tech Solutions Ltd, and aims to serve various markets within the skincare industry.
| 27 Jul 2026 | 07:00:09 | Holding(s) in Company |
| 21 Jul 2026 | 07:00:03 | Holding(s) in Company |
| 29 Jun 2026 | 07:00:13 | IMC Presentation Statement |
| 25 Jun 2026 | 12:00:00 | Directorate change |
| 23 Jun 2026 | 12:03:41 | Notice of Investor Presentation |
| 16 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 17 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 12 Dec 2023 | Annual Report and Accounts (to 2023-06-30) |
Skinbiotherapeutics PLC is a biotechnology company focused on developing products that enhance skin health. The company utilizes its SkinBiotix® technology, which is based on research by Professor Catherine O'Neill and Professor Andrew McBain. Skinbiotherapeutics operates through multiple subsidiaries, including AxisBiotix Limited, Dermatonics Ltd, and Bio-Tech Solutions Ltd, and aims to serve various markets within the skincare industry.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.20bn | -0.4% | |
| £41m | — | |
| £38m | +3.5% | |
| £31m | — | |
SBTXSkinbiotherapeutics PLC | £26m | -0.3% |
| £23m | +1.6% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.20bn | -0.4% | |
| £41m | — | |
| £38m | +3.5% | |
| £31m | — | |
SBTXSkinbiotherapeutics PLC | £26m | -0.3% |
| £23m | +1.6% |
